Mesenchymal stem cells show little tropism for the resting and differentiated cancer stem cell-like glioma cells

Liu,Zhenlin; Jiang,Zhongmin; Huang,Jianyong; Huang,Shuqiang; Li,Yanxia; Sheng,Feng; Yu,Simiao; Yu,Shizhu; Liu,Xiaozhi

doi:10.3892/ijo.2014.2284

Mesenchymal stem cells show little tropism for the resting and differentiated cancer stem cell-like glioma cells

Authors:
- Zhenlin Liu
- Zhongmin Jiang
- Jianyong Huang
- Shuqiang Huang
- Yanxia Li
- Feng Sheng
- Simiao Yu
- Shizhu Yu
- Xiaozhi Liu
View Affiliations

Affiliations: Department of Neurosurgery, The Fifth Central Hospital of Tianjin, Tianjin, P.R. China, Department of Pathology, The Fifth Central Hospital of Tianjin, Tianjin, P.R. China, Department of Biomedical Engineering, Duke University, Durham, NC, USA, Central Laboratory, The Fifth Central Hospital of Tianjin, Tianjin, P.R. China, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Ministry of Education, Tianjin, P.R. China
Published online on: January 28, 2014 https://doi.org/10.3892/ijo.2014.2284
Pages: 1223-1232

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Intrinsic resistance of glioma cells to radiation and chemotherapy is currently hypothesized to be partially attributed to the existence of cancer stem cells. Emerging studies suggest that mesenchymal stem cells may serve as a potential carrier for delivery of therapeutic genes to disseminated glioma cells. However, the tropism character of mesenchymal stem cells for cancer stem cell-like glioma cells has rarely been described. In this study, we obtained homologous bone marrow-derived (BM-) and adipose tissue-derived (AT-) mesenchymal stem cells (MSCs), fibroblast, and cancer stem cell-like glioma cells (CSGCs) from tumor-bearing mice, and compared the tropism character of BM- and AT-MSCs for CSGCs with various form of existence. To characterize the cell proliferation and differentiation, the spheroids of CSGCs were cultured on the surface of the substrate with different stiffness, combined with or withdrew basic fibroblast growth factor (bFGF) and epidermal growth factor (EGF) in medium. Our results showed that the CSGCs during the process of cell proliferation, but not in resting and differentiated status, display strong tropism characteristics on both BM- and AT-MSCs, as well as the expression of their cell chemokine factors which mediate cell migration. If the conclusion is further confirmed, it may expose a fatal flaw of MSCs as tumor-targeted delivery of therapeutic agents in the treatment of the CSGCs, even other cancer stem cells, because there always exist a part of cancer stem cells that are in resting status. Overall, our findings provide novel insight into the complex issue of the MSCs as drug delivery in the treatment of brain tumors, especially in tumor stem cells.

View Figures

View References

1.	Raizer JJ, Grimm S, Chamberlain MC, et al: A phase 2 trial of single-agent bevacizumab given in an every-3-week schedule for patients with recurrent high-grade gliomas. Cancer. 116:5297–5305. 2010. View Article : Google Scholar : PubMed/NCBI
2.	Gilbert CA and Ross AH: Cancer stem cells: cell culture, markers, and targets for new therapies. J Cell Biochem. 108:1031–1038. 2009. View Article : Google Scholar : PubMed/NCBI
3.	Bonavia R, Inda MM, Cavenee WK and Furnari FB: Heterogeneity maintenance in glioblastoma: a social network. Cancer Res. 71:4055–4060. 2011. View Article : Google Scholar : PubMed/NCBI
4.	Masica DL and Karchin R: Correlation of somatic mutation and expression identifies genes important in human glioblastoma progression and survival. Cancer Res. 71:4550–4061. 2011. View Article : Google Scholar : PubMed/NCBI
5.	Huang PH, Cavenee WK, Furnari FB and White FM: Uncovering therapeutic targets for glioblastoma: a systems biology approach. Cell Cycle. 6:2750–2754. 2007. View Article : Google Scholar : PubMed/NCBI
6.	Hide T, Takezaki T, Nakatani Y, et al: Combination of a ptgs2 inhibitor and an epidermal growth factor receptor-signaling inhibitor prevents tumorigenesis of oligodendrocyte lineage-derived glioma-initiating cells. Stem Cells. 29:590–599. 2011. View Article : Google Scholar
7.	Murphy AM and Rabkin SD: Current status of gene therapy for brain tumors. Transl Res. 161:339–354. 2013. View Article : Google Scholar : PubMed/NCBI
8.	Gong A and Huang S: FoxM1 and Wnt/β-catenin signaling in glioma stem cells. Cancer Res. 72:5658–5662. 2012.
9.	Filatova A, Acker T and Garvalov BK: The cancer stem cell niche(s): the crosstalk between glioma stem cells and their microenvironment. Biochim Biophys Acta. 1830:2496–2508. 2013. View Article : Google Scholar
10.	Altaner C and Altanerova V: Stem cell based glioblastoma gene therapy. Neoplasma. 59:756–760. 2012. View Article : Google Scholar : PubMed/NCBI
11.	Patel M, Vogelbaum MA, Barnett GH, Jalali R and Ahluwalia MS: Molecular targeted therapy in recurrent glioblastoma: current challenges and future directions. Expert Opin Investig Drugs. 21:1247–1266. 2012. View Article : Google Scholar : PubMed/NCBI
12.	Serakinci N, Christensen R, Fahrioglu U, Sorensen FB, Dagnæs-Hansen F, Hajek M, Jensen TH, Kolvraa S and Keith NW: Mesenchymal stem cells as therapeutic delivery vehicles targeting tumor stroma. Cancer Biother Radiopharm. 26:767–773. 2011. View Article : Google Scholar
13.	Bak XY, Lam DH, Yang J, Ye K, Wei EL, Lim SK and Wang S: Human embryonic stem cell-derived mesenchymal stem cells as cellular delivery vehicles for prodrug gene therapy of glioblastoma. Hum Gene Ther. 22:1365–1377. 2011. View Article : Google Scholar : PubMed/NCBI
14.	Dai LJ, Moniri MR, Zeng ZR, Zhou JX, Rayat J and Warnock GL: Potential implications of mesenchymal stem cells in cancer therapy. Cancer Lett. 305:8–20. 2011. View Article : Google Scholar : PubMed/NCBI
15.	Hata N, Shinojima N, Gumin J, Yong R, Marini F, Andreeff M and Lang FF: Platelet-derived growth factor BB mediates the tropism of human mesenchymal stem cells for malignant gliomas. Neurosurgery. 66:144–157. 2010. View Article : Google Scholar : PubMed/NCBI
16.	Matuskova M, Baranovicova L, Kozovska Z, Durinikova E, Pastorakova A, Hunakova L, Waczulikova I, Nencka R and Kucerova L: Intrinsic properties of tumour cells have a key impact on the bystander effect mediated by genetically engineered mesenchymal stromal cells. J Gene Med. 14:776–787. 2012. View Article : Google Scholar
17.	Keung EZ, Nelson PJ and Conrad C: Concise review: genetically engineered stem cell therapy targeting angiogenesis and tumor stroma in gastrointestinal malignancy. Stem Cells. 31:227–235. 2013. View Article : Google Scholar : PubMed/NCBI
18.	Kosaka H, Ichikawa T, Kurozumi K, Kambara H, Inoue S, Maruo T, Nakamura K, Hamada H and Date I: Therapeutic effect of suicide gene-transferred mesenchymal stem cells in a rat model of glioma. Cancer Gene Ther. 19:572–578. 2012. View Article : Google Scholar
19.	Doucette T, Rao G, Yang Y, Gumin J, Shinojima N, Bekele BN, Qiao W, Zhang W and Lang FF: Mesenchymal stem cells display tumor-specific tropism in an RCAS/Ntv-a glioma model. Neoplasia. 13:716–725. 2011.PubMed/NCBI
20.	Liu Y, Wang L, Fatahi R, Kronenberg M, Kalajzic I, Rowe D, Li Y and Maye P: Isolation of murine bone marrow derived mesenchymal stem cells using Twist2 Cre transgenic mice. Bone. 47:916–925. 2010. View Article : Google Scholar : PubMed/NCBI
21.	Kisiel AH, McDuffee LA, Masaoud E, Bailey TR, Esparza Gonzalez BP and Nino-Fong R: Isolation, characterization, and in vitro proliferation of canine mesenchymal stem cells derived from bone marrow, adipose tissue, muscle, and periosteum. Am J Vet Res. 73:1305–1317. 2012. View Article : Google Scholar
22.	Dembo M and Wang YL: Stresses at the cell-to-substrate interface during locomotion of fibroblasts. Biophys J. 76:2307–2316. 1999. View Article : Google Scholar : PubMed/NCBI
23.	Qin L, Huang J, Xiong C, Zhang Y and Fang J: Dynamical stress characterization and energy evaluation of single cardiac myocyte actuating on flexible substrate. Biochem Biophys Res Commun. 360:352–356. 2007. View Article : Google Scholar : PubMed/NCBI
24.	Huang J, Peng X, Xiong C and Fang J: Influence of substrate rigidity on primary nucleation of cell adhesion: a thermal fluctuation model. J Colloid Interface Sci. 366:200–208. 2012. View Article : Google Scholar : PubMed/NCBI
25.	Lee J, Elkahloun AG, Messina SA, Ferrari N, Xi D, Smith CL, Cooper R Jr, Albert PS and Fine HA: Cellular and genetic characterization of human adult bone marrow-derived neural stem-like cells: a potential antiglioma cellular vector. Cancer Res. 63:8877–8889. 2003.
26.	Paroo Z, Ye X, Chen S and Liu Q: Phosphorylation of the human microRNA-generating complex mediates MAPK/Erk signaling. Cell. 139:112–122. 2009. View Article : Google Scholar : PubMed/NCBI
27.	Liu N, Landreh M, Cao K, et al: The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila. Nature. 482:519–523. 2012. View Article : Google Scholar : PubMed/NCBI
28.	Bischoff DS, Makhijani NS and Yamaguchi DT: Constitutive expression of human telomerase enhances the proliferation potential of human mesenchymal stem cells. Biores Open Access. 1:273–279. 2012. View Article : Google Scholar : PubMed/NCBI
29.	Sensebé L, Bourin P and Tarte K: Good manufacturing practices production of mesenchymal stem/stromal cells. Hum Gene Ther. 22:19–26. 2011.PubMed/NCBI
30.	Boeuf S and Richter W: Chondrogenesis of mesenchymal stem cells: role of tissue source and inducing factors. Stem Cell Res Ther. 1:312010.PubMed/NCBI
31.	Uccelli A, Morando S, Bonanno S, Bonanni I, Leonardi A and Mancardi G: Mesenchymal stem cells for multiple sclerosis: does neural differentiation really matter? Curr Stem Cell Res Ther. 6:69–72. 2011. View Article : Google Scholar : PubMed/NCBI
32.	Augello A and De Bari C: The regulation of differentiation in mesenchymal stem cells. Hum Gene Ther. 21:1226–1238. 2010. View Article : Google Scholar : PubMed/NCBI
33.	Park JS, Chu JS, Tsou AD, Diop R, Tang Z, Wang A and Li S: The effect of matrix stiffness on the differentiation of mesenchymal stem cells in response to TGF-β. Biomaterials. 32:3921–3930. 2011.PubMed/NCBI
34.	Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, Fiocco R, Foroni C, Dimeco F and Vescovi A: Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 64:7011–7021. 2004.PubMed/NCBI